| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | CLOVIS ONCOLOGY INC | 54,000 | 4,008,000 | 0.68% | ||
| 52 | ABIOMED INC | 55,000 | 3,937,000 | 0.66% | ||
| 53 | Omnicare Inc (Acquired 8/18/2015) | 50,000 | 3,853,000 | 0.65% | ||
| 54 | KERYX BIOPHARMACEUTICALS INCORPORATED | 297,000 | 3,781,000 | 0.64% | ||
| 55 | THORATEC LABS CORP | 87,000 | 3,644,000 | 0.61% | ||
| 56 | RIGEL PHARMACEUTICAL INC | 1,000,000 | 3,570,000 | 0.60% | ||
| 57 | CENTENE CORP DEL | 48,000 | 3,393,000 | 0.57% | ||
| 58 | HOLOGIC INC | 101,000 | 3,336,000 | 0.56% | ||
| 59 | MACROGENICS INC | 106,000 | 3,325,000 | 0.56% | ||
| 60 | CELLDEX THERAPEUTICS INC NEW | 119,000 | 3,317,000 | 0.56% | ||
| 61 | ENDOLOGIX INC | 194,000 | 3,312,000 | 0.56% | ||
| 62 | PERRIGO CO PLC | 20,000 | 3,311,000 | 0.56% | ||
| 63 | ST JUDE MED INC | 48,800 | 3,192,000 | 0.54% | ||
| 64 | ARIAD PHARMACEUTICALS ORD (NMS) | 387,000 | 3,189,000 | 0.54% | ||
| 65 | ANTHERA PHARMACEUTICALS I | 701,314 | 3,135,000 | 0.53% | ||
| 66 | TEVA PHARMACEUTICAL INDS LTD | 50,000 | 3,115,000 | 0.53% | ||
| 67 | TESARO INCORPORATED | 52,999 | 3,042,000 | 0.51% | ||
| 68 | LIGAND PHARMACEUTICALS INC | 39,000 | 3,007,000 | 0.51% | ||
| 69 | INSULET CORPORATION | 90,000 | 3,002,000 | 0.51% | ||
| 70 | DEPHEID | 52,000 | 2,959,000 | 0.50% | ||
| 71 | STRYKER CORP | 32,000 | 2,952,000 | 0.50% | ||
| 72 | ARRAY BIOPHARMA INC | 400,000 | 2,948,000 | 0.50% | ||
| 73 | XENCOR INC COM | 190,000 | 2,911,000 | 0.49% | ||
| 74 | HEARTWARE INTL INC | 33,000 | 2,896,000 | 0.49% | ||
| 75 | OMNICELL INC | 80,000 | 2,808,000 | 0.47% | ||
| 76 | ACHILLION PHARMACEUTICALS IN | 280,000 | 2,761,000 | 0.47% | ||
| 77 | Dynavax Techs Cp New | 122,835 | 2,755,000 | 0.46% | ||
| 78 | EDWARDS LIFESCIENCES CORP | 19,000 | 2,707,000 | 0.46% | ||
| 79 | TANDEM DIABETES CARE INC COM | 209,000 | 2,638,000 | 0.44% | ||
| 80 | KITE PHARMA INCORPORATED | 45,000 | 2,596,000 | 0.44% | ||
| 81 | ENDO INTL PLC | 26,741 | 2,399,000 | 0.40% | ||
| 82 | CELLADON CORP | 120,053 | 2,274,000 | 0.38% | ||
| 83 | MYRIAD GENETICS INC | 60,000 | 2,124,000 | 0.36% | ||
| 84 | AVALANCHE BIOTECHNOLOGIES IN | 43,000 | 1,742,000 | 0.29% | ||
| 85 | * LEXICON PHARMACEUTICALS INC COM | 1,594,805 | 1,506,000 | 0.25% | ||
| 86 | Mirati Therapeutics Inc | 45,388 | 1,331,000 | 0.22% | ||
| 87 | THRESHOLD PHARMACEUTICAL INC | 201,537 | 818,000 | 0.14% | ||
| 88 | BIND THERAPEUTICS INC | 133,535 | 733,000 | 0.12% | ||
| 89 | CHIMERIX INC | 14,200 | 535,000 | 0.09% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-15-001643, filed 2015.05.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
